pages:
-
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
-
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors
-
A Phase 2 Multicenter, Single-Arm, Open-Label Study to Evaluate the Activity, Safety and Pharmacokinetics of Lenalidomide (Revlimid®) in Pediatric Subjects from 1 To < 18 Years of Age with Relapsed or Refractory Acute Myeloid Leukemia
-
A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa
-
A Phase 2/3 Open-label, Randomized, Sequential Dose Escalation Cohort Study of T2307 Versus Standard of Care in Treatment of Subjects with Candidemia due to Candida Auris and other Drug-resistant Candida Species: An Adaptive Design Study
-
A Phase 2A Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients with Acute Liver Failure/Severe Acute Liver Injury (STOP-ALF)
-
A Phase 3 Randomized Controlled Trial of AZM for RSV-Induced Respiratory Failure in Children in the ICU
-
A Phase 3 Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC # 606869) in the Very High Risk Stratum
-
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of LY3819253 in Preventing SARS-CoV-2 Infection and COVID-19 in Skilled Nursing and Assisted Living Facility Residents and Staff - a NIAID and Lilly Collaborative Study
-
A Phase 3 Study of Eltrombopag vs Standard First-Line Management for Newly-Diagnosed Immune Thrombocytopenia (ITP) in Children
-
A Phase I and Pilot Study of the Effect of rhIL-7-hyFc (NT-I7) on CD4 Counts in Patients with High Grade Gliomas and Severe Treatment-Related CD4 Lymphopenia after Concurrent Radiation and Temozolomide
-
A Phase I Open Label Safety Study to Evaluate the Pharmacokinetic Profile and Tolerance of Mibefradil Dose Finding in Subjects with Recurrent High-Grade Glioma Undergoing Standard. Repeated Temozolomide Treatment (TAU-2010-1)
-
A Phase I Study of the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib (INLYTA) in Children with Relapsed Refractory Solid Tumors
-
A Phase I Study to Evaluate the Safety and Immunogenicity of HPV 16 L2 11-200
-
A Phase I Trial of Anti-LAG-3 or Anti-CD137 Alone and in Combination with Anti-PD-1 in Patients with Recurrent GBM
-
A Phase I Trial of IRS-1 HSV C134 Administered Intratumorally in Patients with Recurrent Malignant Glioma
-
A Phase I/II Study of Bosutinib in Pediatric Patients with Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph+ Chronic Myeloid Leukemia, Study ITCC-054/COG AAML1921
-
A Phase I/II Trial of Hydroxychloroquine in Conjunction with Radiation Therapy and Concurrent and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (Therapeutics Studies of Anaplastic Glioma)
-
A Phase II Exploratory, Randomized, Placebo-Controlled Trial of Pomegranate Fruit Extract (PFE/PomX) in Subjects with Clinically Localized Prostate Cancer Undergoing Active Surveillance
-
A Phase II Multi-Center, Randomized, Open-Label, Active-Control, Dose-Ranging Study of Interferon -2B Given Via Continuous Subcutaneous Infusion in Subjects with Hepatitis C Virus Genotype 1 Infection
-
A Phase II Multi-site Study of Autologous Cord Blood Cells for Hypoxic lschemic Encephalopathy (HIE)
-
A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients with Triple-Negative Locally Advanced Breast Cancer
-
A Phase II of Rituximab in Myasthenia Gravis (NN 103)
-
A Phase II Study Evaluating the Efficacy and Tolerability of Everolimus (RAD001) in Combination with Trastuzumab and Vinorelbine in the Treatment of Progressive HER2-Positive Breast Cancer Brain Metastases
-
A Phase II Study of Binimetinib in Combination with Encorafenib in Adults with Recurrent BRAF V600-Mutated High-Grade Astrocytoma or other Primary Brain Tumor
-
A Phase II Study of Durvalumab (MEDI 4736) with Radiotherapy for the adjuvant treatment of Intermediate Risk Head and Neck Squamous Cell Carcinoma
-
A Phase II Study of Everolimus (RAD001) for Children with Neurofibromatosis Type I and Chemotherapy-Refractory Radiographic Progressive Low-Grade
-
A Phase II Study of Sunitinib in Recurrent or Progressive Brain Tumors in Pediatric and Young Adult Patients
-
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial to Assess The Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for The Treatment of Bacterial Vaginosis
-
A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection
pages:
